How do you discuss use of tamoxifen in your stage I breast cancer patients who are > 80 years old weighing in risk of VTE with benefit from adjuvant treatment?

Assuming aromatase inhibitor is not an option due to severe osteoporosis or if it is a man with breast cancer.

Answer from: Medical Oncologist at Academic Institution

The risk of both thrombotic events and endometrial cancer are age-dependent in general - much of this information is best interpreted from the prevention literature, where the numbers are larger, and the impacts of co-morbidities and concomitant medications are less. With tamoxifen use, both the abs...

Comments

Medical Oncologist at Sinai Hospital of Baltimore
What do you do for your older 80+ male patients wi...

Medical Oncologist at University of Texas MD Anderson Cancer Center
For male breast cancer, in general, I prefer to us...

Please select the option that best describes you:

How do you discuss use of tamoxifen in your stage I breast cancer patients who are > 80 years old weighing in risk of VTE with benefit from adjuvant treatment?

Related Questions